Course Content
Zambian Paediatric & Obstetrics-Gynecology (OB/GYN) Clinical Mastery

Paediatric Anaphylaxis 

Lesson Objectives

By the end of this lesson, learners should be able to:

  1. Define anaphylaxis and distinguish it from mild and moderate allergic reactions.

  2. Recognize the common triggers and risk factors for anaphylaxis.

  3. Identify the clinical signs of mild, moderate, and life-threatening reactions.

  4. Apply the ABCDE approach in the urgent management of anaphylaxis.

  5. Know the emergency medications and dosages for paediatric anaphylaxis.

Description

Anaphylaxis is a severe, life-threatening allergic reaction caused by immune-mediated hypersensitivity.
It can lead to airway compromise and circulatory shock.

Common triggers include:

  • Antibiotics

  • Vaccines

  • Blood transfusion

  • Certain foods (e.g., nuts)

  • Medications

Risk factors / associations:

  • Asthma

  • Eczema

  • Family history of allergies

Note: Not all allergic reactions progress to anaphylaxis.

Symptoms and Signs

Mild Allergic Reaction Moderate Allergic Reaction
Mouth itching All mild symptoms plus:
Nausea Red throat
Urticaria Cough
Conjunctivitis Wheeze
Nasal congestion Diarrhoea
  Sweating
  Tachycardia
  Pallor

Life-threatening signs:

  • Airway compromise (stridor, swelling of lips/tongue)

  • Severe wheezing or respiratory distress

  • Hypotension or shock

  • Collapse or unresponsiveness

If any life-threatening signs are present, treat as anaphylaxis immediately.

Treatment (ABCDE Approach)

Step Action / Details
A – Airway Assess and secure airway. Consider early airway adjuncts if swelling is severe. Prepare for intubation if airway compromise is progressive.
B – Breathing Provide 100% oxygen via mask or nasal cannula. Monitor oxygen saturation and respiratory effort. Support ventilation as needed.
C – Circulation Establish two large-bore IV lines or intraosseous access if necessary. Rapid fluid bolus with 0.9% saline 20 mL/kg for shock, repeated as needed. Monitor blood pressure, heart rate, perfusion.
D – Disability / Drugs Administer adrenaline (epinephrine) IM 0.01 mg/kg per dose (max 0.5 mg per dose) in the mid-anterolateral thigh. Repeat every 5–10 minutes if no improvement. Adjunct medications: Antihistamines (chlorphenamine 0.25–0.5 mg/kg IV) and corticosteroids (hydrocortisone 2 mg/kg IV).
E – Exposure / Evaluation Monitor temperature, skin changes, rashes. Assess for trigger identification. Remove exposure to allergen if possible.

Monitoring

  • Continuous monitoring of airway, breathing, circulation, and consciousness.

  • Frequent reassessment of vital signs and perfusion.

  • Observe for biphasic reactions, which may occur hours after initial treatment.

  • Prepare for escalation to ICU if persistent hypotension or severe airway compromise occurs.

Key Points Summary

  • Anaphylaxis is life-threatening and requires immediate intervention.

  • Early administration of IM adrenaline is the cornerstone of treatment.

  • ABCDE assessment ensures structured and rapid stabilization.

  • Adjunct therapy includes antihistamines, corticosteroids, and fluid resuscitation.

  • Remove allergen and monitor for secondary or biphasic reactions.

 

Bookmark